Petros Pharmaceuticals Stock Forecast, Price & News

Petros Pharmaceuticals (NASDAQ:PTPI) Frequently Asked Questions

What stocks does MarketBeat like better than Petros Pharmaceuticals?

Wall Street analysts have given Petros Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Petros Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Petros Pharmaceuticals' next earnings date?

Petros Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, November 16th 2021.
View our earnings forecast for Petros Pharmaceuticals.

How were Petros Pharmaceuticals' earnings last quarter?

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) posted its earnings results on Tuesday, August, 17th. The company reported ($0.45) EPS for the quarter. The company earned $2.46 million during the quarter.
View Petros Pharmaceuticals' earnings history.

Who are Petros Pharmaceuticals' key executives?

Petros Pharmaceuticals' management team includes the following people:

• Mr. John D. Shulman, Exec. Chairman (Age 58)
• Mr. Fady Boctor M.B.A., Pres & Chief Commercial Officer (Age 43)
• Mr. Mitchell S. Arnold M.B.A., VP of Fin. & Chief Accounting Officer (Age 57)
• Mr. Keith F. Lavan, Advisor (Age 57)
• Mr. Andrew Gesek M.B.A., Pres of Timm Medical (Age 50)

Who are some of Petros Pharmaceuticals' key competitors?

Some companies that are related to Petros Pharmaceuticals include Graybug Vision (GRAY), Galmed Pharmaceuticals (GLMD), Chembio Diagnostics (CEMI), ASLAN Pharmaceuticals (ASLN), Aytu Biopharma (AYTU), Advaxis (ADXS), Ainos (AIMD), Liminal BioSciences (LMNL), Longeveron (LGVN), Helix BioPharma (HBPCF), CohBar (CWBR), Rezolute (RZLT), Rezolute (RZLTD), Vaccinex (VCNX) and Celyad Oncology (CYAD).
View all of PTPI's competitors.

What is Petros Pharmaceuticals' stock symbol?

Petros Pharmaceuticals trades on the NASDAQ under the ticker symbol "PTPI."

Who are Petros Pharmaceuticals' major shareholders?

Petros Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Shay Capital LLC (2.44%), NorthRock Partners LLC (2.24%), Vanguard Group Inc. (1.10%), CM Management LLC (1.02%), Renaissance Technologies LLC (0.56%) and Platform Technology Partners (0.45%).

Which major investors are selling Petros Pharmaceuticals stock?

PTPI stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, NorthRock Partners LLC, and Shay Capital LLC.

Which major investors are buying Petros Pharmaceuticals stock?

PTPI stock was bought by a variety of institutional investors in the last quarter, including CM Management LLC, Platform Technology Partners, Vanguard Group Inc., Virtu Financial LLC, and Geode Capital Management LLC.

How do I buy shares of Petros Pharmaceuticals?

Shares of PTPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Petros Pharmaceuticals' stock price today?

One share of PTPI stock can currently be purchased for approximately $1.91.

How much money does Petros Pharmaceuticals make?

Petros Pharmaceuticals has a market capitalization of $18.77 million and generates $9.56 million in revenue each year.

How many employees does Petros Pharmaceuticals have?

Petros Pharmaceuticals employs 27 workers across the globe.

What is Petros Pharmaceuticals' official website?

The official website for Petros Pharmaceuticals is www.petrospharma.com.

Where are Petros Pharmaceuticals' headquarters?

Petros Pharmaceuticals is headquartered at 1185 AVENUE OF THE AMERICAS 3RD FLOOR, NEW YORK NY, 10036.

How can I contact Petros Pharmaceuticals?

Petros Pharmaceuticals' mailing address is 1185 AVENUE OF THE AMERICAS 3RD FLOOR, NEW YORK NY, 10036. The company can be reached via phone at 973-242-0005 or via email at [email protected].